 | |
 | |
| Names | |
|---|---|
| Preferred IUPAC name Methyl 4-ethyl-6,7-dimethoxy-9H-pyrido[3,4-b]indole-3-carboxylate | |
| Other names DMCM | |
| Identifiers | |
3D model (JSmol) | |
| ChemSpider |
|
| ECHA InfoCard | 100.220.168 |
| UNII | |
| |
| |
| Properties | |
| C17H18N2O4 | |
| Molar mass | 314.336 g/mol |
| Boiling point | 87 °C (189 °F; 360 K) |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
DMCM (methyl 6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate) is a drug from theβ-carboline family thatinduces anxiety andconvulsions by acting as anegative allosteric modulator ofGABAA receptors — functionally opposite tobenzodiazepines andrelated drugs which arepositive allosteric modulators — and is used in scientific research for these properties to test newanxiolytic andanticonvulsant medications, respectively.[1][2][3][4] It has also been shown to produceanalgesic effects in animals, which is thought to be the drug's inducedpanic reducing the perception of pain.[5]
 | Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |
